By Michael Erman and Julie Steenhuysen NEW YORK, Oct 20 (Reuters) - Doctors are urging Americans aged 6 months and older to ...

At the European Society of Medical Oncology meeting in Madrid this weekend, analysts will be watching for detailed data on ...

AstraZeneca PLC (AZN) has announced a collaboration with Oracle Health and Life Sciences that pairs AstraZeneca’s scientific, clinical-development and regulatory expertise with Oracle’s ...

According to Zhitong Financial News, AstraZeneca (AZN.US) has announced a collaboration with machine learning biotech company ...

Oct 2 (Reuters) - Chinese biotech company Abogen said on Friday it has signed a licensing deal worth up to $7.8 billion with Novartis to develop messenger RNA-based therapies, underscoring the Swiss ...

Bio / Biotech Weekly Digest for Pharma BD & CVC[Summary of Last Week's Biotech Trends]Last week in the biotech industry was ...

Multiply Labs’ $75 million Series B is a bet that robots can make advanced medicines affordable at industrial scale. Arriving in the middle of ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

A Sidley partner says licenses let Big Pharma cut losses if programs fall short, while upfront and milestone payments bankroll Chinese biotechs that keep developing at home. ING sees China supplying ...

The mRNA revolution didn’t end with COVID-19 – it’s only just beginning. With the MHRA’s latest guidance on personalized mRNA cancer vaccines and the world’s first RNA-based CRISPR therapy changing ...

Multiply Labs raises $75M Series B led by Dr. Patrick Soon-Shiong to scale robotic manufacturing to help patients access next-generation drugs.